Health & Medicinearticle2026-11-05

Deep Learning for AD Risk Screening and Progression Prediction

Open access3 citations

Abstract

Timely intervention for Alzheimer's disease (AD) requires early detection. The development of immunotherapies targeting amyloid-beta and tau underscores the need for accessible, time-efficient biomarkers for early diagnosis. Here, we directly applied our previously developed MRI-based deep learning model for AD to the large Chinese SILCODE cohort (722 participants, 1,105 brain MRI scans). The model - initially trained on North American data - demonstrated robust cross-ethnic generalization, without any retraining or fine-tuning, achieving an AUC of 91.3% in AD classification with a sensitivity of 95.2%. It successfully identified 86.7% of individuals at risk of AD progression more than 5 years in advance. Individuals identified as high-risk exhibited significantly shorter median progression times. By integrating an interpretable deep learning brain risk map approach, we identified AD brain subtypes, including an MCI subtype associated with rapid cognitive decline. The model's risk scores showed significant correlations with cognitive measures and plasma biomarkers, such as tau proteins and neurofilament light chain (NfL). These findings underscore the exceptional generalizability and clinical utility of MRI-based deep learning models, especially in large and diverse populations, offering valuable tools for early therapeutic intervention. The model has been made open-source and deployed to a free online website for AD risk prediction, to assist in early screening and intervention.

// Source

View paper (DOI)Open access versionOpenAlexAdvanced SciencePublished 2026-11-05

Authors: Bin Lu, Yanrong Chen, Ruixian Li, Mingkai Zhang, Shaozhen Yan, Guanqun Chen, Jing‐Hua Wang, Wen‐Hui Chai, F. Xavier Castellanos, Dan Joseph Stein, Jie Lu, Ying Mei Han, Chao‐Gan Yan

Institutions: Chinese Academy of Sciences, University of North Carolina at Chapel Hill, University of Chinese Academy of Sciences, University of Southern California, Radboud University Nijmegen, New York University, Tsinghua University, Capital Medical University, Beijing Chao-Yang Hospital, Capital Medical University, Hainan University, Affiliated Hospital of Hangzhou Normal University, Xuan Wu Hospital of the Capital Medical University, Donders Institute for Brain, Cognition and Behaviour, Donders Centre for Cognitive Neuroimaging